PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 10 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Aqueous and ethanolic leaf extracts (300 mg/kg) attenuated toxicity in rat models [PMID:37207283]
Aqueous lyophilized extract (100-300 mg/kg) showed anti-ulcer properties in cold water and methylene blue-induced ulceration models [PMID:38721816]
Phenylpropanoid glycosides isolated from roots exhibited potent in vitro antiviral activity [PMID:9599250]
Ethyl acetate leaf extract showed significant in vitro anti-parasitic activity, with specific compounds exhibiting mild anti-leishmanial and anti-trypanosomal activities [PMID:19679323]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 37207283 (2024) — Markhamia lutea leaves aqueous and ethanolic extract with curative anti-inflammatory activity attenuates paclitaxel toxicity in rat's intestine. · Journal of complementary & integrative medicine
- 2.PMID: 38721816 (2024) — Anti-inflammatory, anti-oxidant and anti-ulcer activities of aqueous lyophilizate of Markhamia lutea (Bignoniaceae). · Journal of complementary & integrative medicine
- 3.PMID: 27041874 (2016) — Review of the Phytochemical and Pharmacological Studies of the Genus Markhamia. · Pharmacognosy reviews
- 4.PMID: 9599250 (1998) — Antiviral phenylpropanoid glycosides from the medicinal plant Markhamia lutea. · Journal of natural products
- 5.PMID: 19679323 (2009)